IP Library › Assignment 041541/0166
Patent Assignment
Reel/Frame 041541/0166

Change of Name

Recorded: 2017-01-27 Pages: 2
Assignor
PHARMACOFORE, INC.
Executed: 2012-01-04
Assignee
SIGNATURE THERAPEUTICS, INC.
1731 EMBARCADERO ROAD, SUITE 220, PALO ALTO, CALIFORNIA, 94303
Covered Property (1)
Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
Application: 15/285,818 →
Publication: US 2017/0119754
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 27, 2017
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 041112/0182 →
Security Interest Oct 4, 2021
From: ENSYSCE BIOSCIENCES, INC.
To: 3I, LP
Reel/Frame 057785/0054 →
Security Interest Jul 8, 2022
From: ENSYSCE BIOSCIENCES, INC.; EBI OPCO, INC.; EBI OPERATING, INC.; COVISTAT, INC.
To: 3I, LP
Reel/Frame 060616/0487 →
Security Interest Nov 14, 2023
From: ENCSYSCE BIOSCIENCES, INC.
To: 3I, LP
Reel/Frame 065553/0389 →
Security Interest Dec 18, 2023
From: ENSYSCE BIOSCIENCES, INC.; EBI OPCO, INC.; EBI OPERATING, INC.; EBIR, INC.
To: 3I, LP
Reel/Frame 065902/0035 →